# reload+after+2024-01-21 07:43:10.769071
address1§737 North Fifth Street
address2§Suite 200
city§Richmond
state§VA
zip§23219
country§United States
phone§650 870 1200
website§https://www.aditxt.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. It is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
fullTimeEmployees§61
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Amro A. Albanna', 'age': 53, 'title': 'Co-Founder, Chairman & CEO', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 500000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Shahrokh  Shabahang D.D.S., M.S., Ph.D.', 'age': 60, 'title': 'Co-Founder, Chief Innovation Officer, Secretary & Director', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 325000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Thomas J. Farley CPA', 'age': 50, 'title': 'Chief Financial Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 360833, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Corinne D. Pankovcin CPA, M.B.A.', 'age': 57, 'title': 'Chief Commercialization Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'totalPay': 385000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Rowena  Albanna', 'age': 57, 'title': 'Chief Operating Officer', 'yearBorn': 1966, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer  Lee', 'title': 'Director of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Dolly B. Tyan Ph.D.', 'title': 'Senior Vice President of Clinical Development \x96 Transplantation', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ge  Chen M.D., M.S.', 'title': 'Senior Vice President of Preclinical Research & Discovery', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.052
priceToSalesTrailing12Months§3.0007951
currency§USD
dateShortInterest§1702598400
forwardEps§-11.29
exchange§NCM
quoteType§EQUITY
shortName§Aditxt, Inc.
longName§Aditxt, Inc.
firstTradeDateEpochUtc§1593523800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f1a690cd-ba99-37b7-a57e-7f10c4ee72bb
gmtOffSetMilliseconds§-18000000
targetHighPrice§61.0
targetLowPrice§61.0
targetMeanPrice§61.0
targetMedianPrice§61.0
recommendationMean§2.5
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.179
grossMargins§0.14455
ebitdaMargins§0.0
trailingPegRatio§None
